MX9805713A - Tabletas con un alto contenido de famciclovir. - Google Patents

Tabletas con un alto contenido de famciclovir.

Info

Publication number
MX9805713A
MX9805713A MX9805713A MX9805713A MX9805713A MX 9805713 A MX9805713 A MX 9805713A MX 9805713 A MX9805713 A MX 9805713A MX 9805713 A MX9805713 A MX 9805713A MX 9805713 A MX9805713 A MX 9805713A
Authority
MX
Mexico
Prior art keywords
content
famciclovir
tablets
famciclovir tablets
tablet
Prior art date
Application number
MX9805713A
Other languages
English (en)
Inventor
Michael John Greenway
Jennifer Mary Slater
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9805713A publication Critical patent/MX9805713A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una tabla farmacéutica en donde el ingrediente activo es famciclovir y en donde el porcentaje en peso del famciclovir en la tableta es de 85% o mayor.
MX9805713A 1996-01-16 1998-07-15 Tabletas con un alto contenido de famciclovir. MX9805713A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
MX9805713A true MX9805713A (es) 1998-10-31

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9805713A MX9805713A (es) 1996-01-16 1998-07-15 Tabletas con un alto contenido de famciclovir.

Country Status (38)

Country Link
US (1) US6765007B1 (es)
EP (1) EP0874632B1 (es)
JP (2) JP4711360B2 (es)
KR (1) KR100338829B1 (es)
CN (1) CN1132582C (es)
AP (2) AP747A (es)
AR (1) AR005456A1 (es)
AT (1) ATE220910T1 (es)
AU (1) AU713090B2 (es)
BG (1) BG63488B1 (es)
BR (1) BR9706982A (es)
CY (1) CY2390B1 (es)
CZ (1) CZ287205B6 (es)
DE (1) DE69714215T2 (es)
DK (1) DK0874632T3 (es)
DZ (1) DZ2159A1 (es)
EA (1) EA001946B1 (es)
EG (1) EG23684A (es)
ES (1) ES2180922T3 (es)
GB (1) GB9600847D0 (es)
HK (1) HK1016473A1 (es)
HU (1) HU225472B1 (es)
IL (1) IL124913A0 (es)
MX (1) MX9805713A (es)
MY (1) MY127527A (es)
NO (1) NO315689B1 (es)
NZ (1) NZ326769A (es)
OA (1) OA10812A (es)
PE (1) PE35498A1 (es)
PL (1) PL187291B1 (es)
PT (1) PT874632E (es)
SK (1) SK282132B6 (es)
TR (1) TR199800954T2 (es)
TW (1) TW434016B (es)
UA (1) UA63897C2 (es)
UY (2) UY24437A1 (es)
WO (1) WO1997025990A1 (es)
ZA (1) ZA97310B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
KR101710148B1 (ko) 2009-06-26 2017-02-27 타리스 바이오메디컬 엘엘씨 이식가능한 약물전달 디바이스에 사용되기 위한 고체 약물 정제
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
DE69207656T2 (de) * 1991-01-30 1996-10-17 Wellcome Found Wasserlösliche tabletten
EP0586523A4 (en) 1991-05-15 1995-11-29 Univ Yale Determination of prodrugs metabolizable by the liver and therapeutic use thereof
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
UY24437A1 (es) 1997-06-06
NZ326769A (en) 2000-05-26
NO315689B1 (no) 2003-10-13
HK1016473A1 (en) 1999-11-05
AP9700911A0 (en) 1997-01-31
TR199800954T2 (xx) 1998-10-21
JP2000503311A (ja) 2000-03-21
NO983259D0 (no) 1998-07-15
AP9801298A0 (en) 1998-09-30
CY2390B1 (en) 2004-09-10
CZ225498A3 (cs) 1998-12-16
US6765007B1 (en) 2004-07-20
UA63897C2 (en) 2004-02-16
BG102638A (en) 1999-07-30
PL187291B1 (pl) 2004-06-30
HU225472B1 (en) 2006-12-28
ES2180922T3 (es) 2003-02-16
KR100338829B1 (ko) 2002-07-18
MY127527A (en) 2006-12-29
EP0874632A1 (en) 1998-11-04
GB9600847D0 (en) 1996-03-20
PT874632E (pt) 2002-10-31
KR19990077229A (ko) 1999-10-25
AP747A (en) 1999-05-03
OA10812A (en) 2003-01-29
PE35498A1 (es) 1998-08-07
JP4711360B2 (ja) 2011-06-29
DE69714215D1 (de) 2002-08-29
AU1541897A (en) 1997-08-11
EA199800573A1 (ru) 1999-02-25
EP0874632B1 (en) 2002-07-24
CN1132582C (zh) 2003-12-31
SK282132B6 (sk) 2001-11-06
CN1208350A (zh) 1999-02-17
NO983259L (no) 1998-07-15
PL327922A1 (en) 1999-01-04
UY24556A1 (es) 2001-08-27
CZ287205B6 (en) 2000-10-11
JP2009091362A (ja) 2009-04-30
ATE220910T1 (de) 2002-08-15
DE69714215T2 (de) 2003-01-23
BR9706982A (pt) 1999-07-20
HUP9901021A2 (hu) 1999-08-30
DK0874632T3 (da) 2002-11-11
AR005456A1 (es) 1999-06-23
SK95698A3 (en) 1999-01-11
AP1114A (en) 2002-10-18
AU713090B2 (en) 1999-11-25
IL124913A0 (en) 1999-01-26
HUP9901021A3 (en) 2000-08-28
TW434016B (en) 2001-05-16
BG63488B1 (bg) 2002-03-29
WO1997025990A1 (en) 1997-07-24
DZ2159A1 (fr) 2002-12-01
ZA97310B (en) 1997-10-23
EG23684A (en) 2007-05-09
EA001946B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
IL116830A0 (en) Tablets comprising valaciclovir their preparation and use
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
IL106693A (en) Controlled sustained release tablets containing bupropion hydrochloride
HK1017850A1 (en) An associations of active principles containing clopidogrel and an antithrombotic agent
CA2214575A1 (en) Paroxetine tablets and process to prepare them
HUP9602601A3 (en) Piperidine and piperazine derivatives, medicines containing them as active ingredient and their use
ATE128031T1 (de) Direktkomprimierte cholestyramintablette und lösungsmittelfreier überzug dafür.
IL101679A0 (en) Pharmaceutical tablet formulation
CA2283408A1 (en) Swallow tablet comprising paracetamol
AU3720193A (en) Hydroisoindolines and hydroisoquinolines as psychotropic drugs
EP0676963A4 (en) PHARMACEUTICAL COMPOSITIONS BASED ON HYALURONIC ACID AND UREA AND THEIR USE.
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
ZA949296B (en) Sustained release compositions and a method of preparing pharmaceutical compositions.
AU3656189A (en) Pharmaceutical granules and tablets made therefrom
AU5650894A (en) Tachyquinine antagonists, their preparation and use in pharmaceutical formulations
MX9805713A (es) Tabletas con un alto contenido de famciclovir.
AU128017S (en) Pharmaceutical tablet
CA2185242A1 (en) Sustained release tablet containing diclofenac-na
GB2295966B (en) Direct compression tablets
CA2240462A1 (en) High-content famciclovir tablets
AU129056S (en) Pharmaceutical tablet
NZ325404A (en) Disintegratable tablets comprising active, deformable and disintegratable pellets
AU4143093A (en) Pharmaceutical compositions containing amidines and novel amidines
CA2103666A1 (en) Products containing verapamil and trandolapril
CA2084919A1 (en) Sustained release tablets